Paper Details

  1. Home
  2. Paper Details

Trends and variations in intravenous vitamin D use among hemodialysis patients in the United States.

Author: BeaubrunAnne C, BrookhartM Alan, KshirsagarAbhijit V, SleathBetsy, WangLily

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

This study describes patterns and variations in the use of vitamin D formulations (calcitriol, paricalcitol, and doxercalciferol) in hemodialysis patients in the United States. Paricalcitol was the most frequently used formulation, and significant variations were observed in the geographic distribution of vitamin D doses.
Paper Details　
Original Abstract of the Article :
Injectable vitamin D agents are commonly used to manage secondary hyperparathyroidism in dialysis patients. Yet, there are few data documenting the trends and geographic variations in the use of these agents in large, representative samples. We sought to describe patterns and variations in the use o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/23088380

データ提供：米国国立医学図書館（NLM）

Vitamin D Use in Hemodialysis Patients: A Closer Look

Injectable vitamin D agents are commonly used to manage secondary hyperparathyroidism in hemodialysis patients. This study investigates the trends and geographic variations in the use of vitamin D formulations in hemodialysis patients in the United States. The researchers analyzed data from the United States Renal Data System, examining the use of calcitriol, paricalcitol, and doxercalciferol.

Vitamin D Use: Patterns and Variations

The study found a significant increase in the use of intravenous vitamin D formulations among hemodialysis patients over the study period. Paricalcitol was the most commonly used formulation, and there were notable variations in vitamin D use by race, sex, age, and geographic location.

Hemodialysis Care: Optimizing Vitamin D Therapy

This research highlights the importance of understanding the trends and variations in vitamin D use among hemodialysis patients. Further research is needed to assess the potential effects of different vitamin D formulations on patient outcomes.

Dr. Camel's Conclusion

Imagine vitamin D as a precious oasis in the desert of kidney disease. This study sheds light on the complexities of providing this essential vitamin to hemodialysis patients. By understanding the variations in vitamin D use and its potential effects, we can work towards optimizing treatment for these patients.

Date :
  1. Date Completed 2013-07-02
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

23088380

DOI: Digital Object Identifier

NIHMS867605

Related Literature

Article Analysis
・Effects of doxercalciferol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.